Four directors to buy 9 lakh Square Pharma shares | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Tuesday
July 08, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
TUESDAY, JULY 08, 2025
Four directors to buy 9 lakh Square Pharma shares

Pharma

TBS Report
07 April, 2022, 10:10 pm
Last modified: 07 April, 2022, 10:13 pm

Related News

  • Square Pharma posts double-digit growth, earns Tk5,785cr in 9 months
  • Square Pharma declares record dividend, Tk500cr expansion plan
  • Square Pharma earns Tk6,286cr revenue in nine months
  • Square Pharma chairman announces to buy 20 lakh shares
  • Another Square Pharma director to buy 10 lakh shares worth Tk21cr

Four directors to buy 9 lakh Square Pharma shares

TBS Report
07 April, 2022, 10:10 pm
Last modified: 07 April, 2022, 10:13 pm
Photo: Courtesy
Photo: Courtesy

Samuel S Chowdhury, Tapan Chowdhury, Anjan Chowdhury and Ratna Patra – directors of Square Pharmaceuticals Ltd – have announced to buy 2.25 lakh of the company shares each from the public market by 28 April.

"We believe this (the current market price) is not the fair price for the company shares and we have a strong confidence in the company's future," Tapan Chowdhury told The Business Standard. 

"We, the four siblings, try to do things together and that is why each announced to buy the same number of shares," said Tapan Chowdhury, who is also the managing director of the country's top drug manufacturer.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

Following the announcement, Square Pharma shares closed 1.4% higher at Tk221.4 on the Dhaka Stock Exchange (DSE) on Thursday.

Stockbrokers said it gave the spiralling down stock market a hand as the major indices closed slightly higher than the intraday low, unlike the last three days.

Square Pharmaceuticals shares are trading at almost their historic low valuation in terms of price to earnings (PE) ratio, said equity analysts.

According to the DSE, the stock is selling 12.31 times higher than its latest annual earnings per share (EPS) while based on the half-yearly EPS, the ratio is 10.17.

Kenyan plant awaits prestigious inauguration

Following a pandemic disruption and a year of delay, Square's pharma plant in Kenya got fully ready later last year.

Square has already invested $20 million to build the facilities near Nairobi aiming for a stronger presence in the African drugs market and the Kenyan media reported that the investment might go up in phases.

Right now, the plant is going through trial productions and the company is waiting for a fine morning in May-June when Prime Minister Sheikh Hasina (online) and Kenyan President Uhuru Kenyatta (in person) would make a common time to inaugurate the commercial production of the plant, according to Tapan Chowdhury.

At a similar timeline, the company is going to launch its new local unit in Pabna, he added.

Economy / Top News

Square Pharma

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Representational image. Photo: Collected
    US tariff on Bangladeshi goods may exceed 50% with newly imposed tariff
  • Finance Adviser Saleh Uddin Ahmed. Sketch: TBS
    US tariff on Bangladeshi goods not final, can be reduced through negotiations: Finance adviser
  • Why Bangladesh's tariff talks with the US were unsuccessful
    Why Bangladesh's tariff talks with the US were unsuccessful

MOST VIEWED

  • The Mitsubishi Xpander is built with families in mind, ready to handle the daily carpool, grocery runs, weekend getaways, and everything in between. PHOTO: Akif Hamid
    Now made-in-Bangladesh: 2025 Mitsubishi Xpander
  • Illustration: Ashrafun Naher Ananna/TBS Creative
    World’s largest container shipping companies
  • Representational image
    Dhaka gets relief as Trump pushes tariff deadline to 1 Aug
  • A quieter scene at Dhaka University’s central library on 29 June, with seats still unfilled—unlike earlier this year, when the space was overwhelmed by crowds of job aspirants preparing for competitive exams. Photo: Tahmidul Alam Jaeef
    No more long queues at DU Central Library. What changed?
  • Illustration: Duniya Jahan/TBS Creative
    Inflation drops below 9% after 27 months
  • Illustration: Duniya Jahan/TBS Creative
    Young population believe BNP to get 39% of votes, Jamaat 21%, NCP 16% in national polls: Sanem survey

Related News

  • Square Pharma posts double-digit growth, earns Tk5,785cr in 9 months
  • Square Pharma declares record dividend, Tk500cr expansion plan
  • Square Pharma earns Tk6,286cr revenue in nine months
  • Square Pharma chairman announces to buy 20 lakh shares
  • Another Square Pharma director to buy 10 lakh shares worth Tk21cr

Features

Dr Mostafa Abid Khan. Sketch: TBS

Actual impact will depend on how US retailers respond: Mostafa Abid Khan

9h | Economy
Thousands gather to form Bangla Blockade in mass show of support. Photo: TBS

Rebranding rebellion: Why ‘Bangla Blockade’ struck a chord

1d | Panorama
The Mitsubishi Xpander is built with families in mind, ready to handle the daily carpool, grocery runs, weekend getaways, and everything in between. PHOTO: Akif Hamid

Now made-in-Bangladesh: 2025 Mitsubishi Xpander

1d | Wheels
Students of different institutions protest demanding the reinstatement of the 2018 circular cancelling quotas in recruitment in government jobs. Photo: Mehedi Hasan

5 July 2024: Students announce class boycott amid growing protests

3d | Panorama

More Videos from TBS

July-August uprising in memory of Chatradal leader

July-August uprising in memory of Chatradal leader

28m | TBS Stories
Solar panels to be installed in government buildings, educational institutions, hospitals within six months

Solar panels to be installed in government buildings, educational institutions, hospitals within six months

1h | TBS Insight
News of The Day, 08 JULY 2025

News of The Day, 08 JULY 2025

1h | TBS News of the day
Trump sends letter to Yunus imposing 35% tariff on Bangladeshi products

Trump sends letter to Yunus imposing 35% tariff on Bangladeshi products

2h | TBS Economy
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net